Alkene Synthesis (Part 1)

Alkene can be synthesized by a various ways. Alkene can be made from a carbonyl, alkyne, alkane, alchols, alkyl halide and vicinal dibromides and other elimination reactions. We will split the 7 methods of alkene synthesis into 4 parts.

Part 1: Alkyl halide and vicinal dibromide
Part 2: Alcohol, alkyne and alkane
Part 3: Hofmann & Cope Elimination
Part 4: Wittig

Dehydrohalogenation of Alkyl halide 
We already talk about how to synthesize alkene from a E2 (E1 is not considered because it often produces a mixture of SN1 and E1 products) reaction. Dehydrohalogenation of a alkyl halide is actually another name describing the same reaction we previously discussed in the E2 section. The alkyl halide loses a proton and a leaving group with a formation of an alkene. Remember that it is a stereospecific reaction (anti-coplanar) and the Zaitsev product is the major product (the opposite of a Zaitsev product is a Hofmann product, which is a less substituted alkene).

E2 of a alkyl halide


Debromination of Vicinal Dibromides
A vicinal dibromide has two bromines connected on two adjacent carbon atoms. This reaction has a similar mechanism as the E2. The two bromines have to be anti-coplanar. A bromine atom is removed by an iodide ion (instead of a base in E2), then the other bromine leaves, a pi bond is formed between the two carbon atoms. In the example shown, note that the alkene product is stereospecific.

Debromination of vicinal dibromide

Comments

Post a Comment

Popular posts from this blog

What is Pepsin?

Image
In Your Body... Pepsin is a digestive enzyme that performed the best in the acidic condition (pH 2) produced by the gastric juice. It digests and breaks down protein (e.g. meat, seeds, eggs, dairy products, etc.). Keep in mind that pepsin digests proteins (not carbohydrates, not fat) into peptides. These peptides are then either absorbed in the intestine or further break down by enzymes from pancreas. In small intestine (pH around 7), pepsin is no longer effective and no longer digests proteins. Hormones Hormones that regulate digestion and hunger such as gastrin and secretin stimulates the production of pepsinogen, the proenzyme of pepsin. In other words, when pepsinogen is activated, it becomes pepsin.
Read more

The structure of Chimeric Antigen Receptor (CAR) III - Transmembrane Domains

Image
Transmembrane Domains Among the four components of a chimeric antigen receptor (CAR), the transmembrane domain is the least studied one. How different transmembrane domains affect and contribute to each other's functions is also not well studied. That being said, we will go through the function of a transmembrane domain of a CAR, the CD3ζ transmembrane domain, and the CD8α transmembrane domain.  Introduction of the transmembrane domain The transmembrane domain is where the transmembrane proteins are located. In a CAR, the transmembrane domain has the function to anchor the CAR to the T cell membrane. How strong the CAR is anchored to the T cell membrane affects the CAR expression level and stability.  Currently, the commonly used transmembrane domain is derived from proteins such as CD3ζ, CD4, CD8α, and CD28. The CD3ζ transmembrane domain Among the transmembrane domains mentioned, the CD3ζ transmembrane may improve CAR-mediated T cell action as the CD3ζ transmembrane medi...
Read more

The structure of Chimeric Antigen Receptor (CAR) I - Extracellular Target Antigen Binding Domains

Image
Antigen Binding Domains The antigen-binding domain of a chimeric antigen receptor is like the head of a train. It determines the target antigen specificity.  The antigen-binding site is made up of a heavy chain and a light chain joined together to form a single-chain variable fragment (scFv).  Single-chain variable fragment (scFv) scFv targets extracellular surface cancer antigens, the biomarkers of the tumor cells. Classically, CD19 is presented in B cells in leukemia. Hence, CD19 is the biomarker that we want the CAR to recognize and bind with it. Once the scFv of a CAR binds with the target antigen, the immune response, major histocompatibility complex (MHC)-independent T cell activation, results. This is when a cascade of molecular signaling starts to trigger an immune response to kill the tumor cells.  MHC-dependent, T cell receptors (TCR)-mimic CARs Some may call it an improvement, but a T cell receptor (TCR)-mimic CAR functions well when it targets intracellular tu...
Read more